En español
NIDA

Menu

Health and Medical Professionals

Advancing Psychiatric Practice through the Science of Addiction

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, will present a special research track at the American Psychiatric Association’s (APA’s) 166th annual meeting in San Francisco from May 18 to 22.

Tags

Nota de la Directora

El abuso y uso no médico de medicamentos de prescripción es un problema grave de salud pública en los Estados Unidos. Aunque la mayoría de las personas toman los medicamentos de prescripción de manera responsable, se calcula que unas 52 millones de personas (el 20 por ciento de las personas de 12 años y mayores) han consumido medicamentos de prescripción por razones no médicas al menos una vez en su vida, y los jóvenes tienen una representación importante en este grupo.

Tags

Marijuana's Lasting Effects on the Brain

NIDA Director Nora Volkow

March 2013

UPDATE - March 21,2013 – A study was published in January 2013 contesting the interpretation of the large-scale marijuana study I discuss below—that heavy cannabis use begun in the teen years and continued into adulthood brings about declines in IQ scores.

Tags

White House Drug Policy Office and National Institute on Drug Abuse Unveil New Training Materials to Combat National Prescription Drug Abuse Epidemic

Today, the Office of National Drug Control Policy (ONDCP) and the National Institute on Drug Abuse (NIDA) launched a new online learning tool which will provide training for healthcare providers on proper prescribing and patient management practices for patients on opioid analgesics (painkillers)

Tags

NIH selects 11 Centers of Excellence in Pain Education

The National Institutes of Health Pain Consortium has selected 11 health professional schools as designated Centers of Excellence in Pain Education (CoEPEs).

Tags

Medication-Assisted Treatment for Opioid Addiction

Opioids act on specific receptors in the brain and the body, which also interact with naturally produced substances known as endorphins or enkephalins – important in regulating pain. While prescription pain relievers can be highly beneficial if used as prescribed, opioids as a general class of drugs have a high potential for abuse.

Tags

Blending conference translates substance abuse research into practice

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia.

Tags

Pages

Subscribe to RSS - Health and Medical Professionals

Attention

Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

USA.gov

Looking for Treatment?

Use the SAMHSA Treatment Locator or 1-800-662-HELP.

Helpline open during government shutdown